Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
It is a dual agonist for the Glucose-Dependent Insulinotropic Polypeptide (GIP) and GLP-1 receptors, which offers a unique approach to improving glycemic control as well as promoting weight loss
Its not speculation
2 These medications alter glucose metabolism, gastric motility and sympathetic tone, which may lead to unique uptake patterns on PET/CT
For patients seeking weight-loss coverage, providers might recommend alternatives that are FDA-approved for weight management, like Wegovy or Zepbound
US$ 23.22
US$ 23.51
US$ 25.77
.webp)
US$ 20.88
